Mirapex May Increase Heart Failure Risk, FDA Says

Law360, Chicago (September 19, 2012, 1:49 PM EDT) -- The U.S. Food and Drug Administration warned Wednesday that there could be an increased risk of heart failure associated with the Parkinson's drug Mirapex, though further review of data for the medication is needed.

The FDA evaluated a pooled analysis of randomized clinical trials for Mirapex — known genericically as pramipexole and used to treat restless legs syndrome as well — and found that heart failure was more frequent with the drug than with a placebo, though those results were not statistically significant, it said....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.